Document ID: chunk:federal_register_of_legislation:F2024C01066:reg:7:p2
Version: federal_register_of_legislation:F2024C01066
Segment Type: reg
Provision Reference: reg 7 (pt 2/3)
Character Range: 18729–21615

must be marked in the A section (or each A section):
 (a) if an election by the approved supplier is in force under subsection 31(3) of the Commonwealth price (Pharmaceutical benefits supplied by approved pharmacists) Determination 2020, and the prescription is in respect of an extemporaneously‑prepared pharmaceutical benefit that is not a standard formula preparation—the price worked out by the approved supplier in accordance with section 18 of that determination; or
 (b) if no election by the approved supplier is in force under subsection 31(3) of the Commonwealth price (Pharmaceutical benefits supplied by approved pharmacists) Determination 2020, and the prescription is an exceptional prescription—the price worked out by the approved supplier in accordance with section 18 of that determination; or
 (c) if the prescription is in respect of an extemporaneously‑prepared pharmaceutical benefit that is ear drops, eye drops or nasal instillations, and the supply of the benefit in a glass bottle container is specified by the PBS prescriber or considered necessary by the approved supplier—the words "glass bottle".
Note: The RPBS provides that an RPBS claim is to be made in accordance with section 99AAA of the Act and this instrument except if the RPBS otherwise provides. If an RPBS claim is made using the manual system, RPBS prescriptions relating to the claim are given to the Chief Executive Medicare on behalf of the Secretary. The RPBS requires the provision of a serial number that uniquely identifies the RPBS benefit within the category "R", being a serial number marked on the "S" section of the prescription by the approved supplier, commencing at "R1" in each claim and continuing consecutively in respect of that claim made in accordance with this section.
 (9) The prescriptions referred to in subsections (3) to (8) must be grouped according to whether they are covered by paragraph (5)(a), (b), (c) or (d), with the prescriptions in each group sorted in accordance with the serial numbers allotted under the relevant paragraph, starting with the first number allotted.
Note: The RPBS also requires an approved supplier to create a group of RPBS prescriptions sorted in accordance with the "R" serial numbers allotted to the prescriptions, starting with the first number allotted.

Claim made using Claims Transmission System
 (10) If the approved supplier's claim is made using the Claims Transmission System, the approved supplier must comply with the requirements of subsections (3) to (9) in relation to the prescriptions on the presentation of which the pharmaceutical benefits that are the subject of the claim were supplied, except that the prescriptions need not accompany the information given in accordance with this section.

Exception for medication chart prescriptions
 (11) For the purposes of this section, a reference to a prescription does